Since multiple tumor cells proved to depend on Sema6C signaling for proliferation, and its high expression promoted an aggressive phenotype in culture, our data support the idea that Sema6C-targeting may have beneficial effects for cancer therapy. The gene discussed is SEMA6C; the disease is neoplasm.